BBIO

Neutral

BridgeBio Pharma (BBIO) director awarded RSUs and stock options

BridgeBio Pharma director Eric Aguiar was granted 3,990 restricted stock units (RSUs) and 5,277 stock options with an exercise price of $68.92 per sha...

Stock Titan 1 week ago 0

Neutral

BridgeBio Pharma, Inc. $BBIO Position Lifted by Franklin Resources Inc.

Franklin Resources Inc. raised its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 49.9% during the fourth quarter, according...

tickerreport 3 weeks ago 0